CHETONI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 15.599
AS - Asia 8.176
EU - Europa 7.140
SA - Sud America 869
AF - Africa 302
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.109
Nazione #
US - Stati Uniti d'America 15.141
IT - Italia 2.869
CN - Cina 2.452
SG - Singapore 2.446
HK - Hong Kong 1.272
SE - Svezia 964
BR - Brasile 732
DE - Germania 619
VN - Vietnam 607
BG - Bulgaria 563
CA - Canada 406
UA - Ucraina 391
TR - Turchia 350
GB - Regno Unito 342
KR - Corea 337
FR - Francia 314
FI - Finlandia 313
RU - Federazione Russa 283
IN - India 193
JP - Giappone 184
CH - Svizzera 169
CI - Costa d'Avorio 119
AT - Austria 58
BD - Bangladesh 53
NG - Nigeria 52
IQ - Iraq 46
AR - Argentina 43
BE - Belgio 39
ES - Italia 38
NL - Olanda 37
PL - Polonia 37
ID - Indonesia 31
PK - Pakistan 29
SN - Senegal 27
ZA - Sudafrica 25
MX - Messico 24
CZ - Repubblica Ceca 21
UZ - Uzbekistan 21
SA - Arabia Saudita 20
VE - Venezuela 20
GR - Grecia 18
PH - Filippine 18
EC - Ecuador 17
CO - Colombia 15
CL - Cile 14
IE - Irlanda 14
MA - Marocco 14
AE - Emirati Arabi Uniti 13
EG - Egitto 12
JO - Giordania 12
KE - Kenya 12
MY - Malesia 12
NP - Nepal 12
PE - Perù 12
AU - Australia 11
BJ - Benin 10
DK - Danimarca 10
TN - Tunisia 10
LT - Lituania 9
PT - Portogallo 8
PY - Paraguay 8
AZ - Azerbaigian 7
IL - Israele 7
TW - Taiwan 7
DZ - Algeria 6
EU - Europa 6
IR - Iran 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
JM - Giamaica 5
PA - Panama 5
CR - Costa Rica 4
ET - Etiopia 4
LB - Libano 4
MN - Mongolia 4
RO - Romania 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
BN - Brunei Darussalam 3
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
OM - Oman 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
PR - Porto Rico 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
Totale 32.089
Città #
Woodbridge 1.523
Singapore 1.395
Ann Arbor 1.391
Ashburn 1.382
Hong Kong 1.252
Chandler 1.053
Fairfield 873
Houston 868
Santa Clara 839
San Jose 720
Serra 694
Milan 642
Dallas 610
Sofia 563
Jacksonville 505
Beijing 498
Shanghai 403
New York 364
Ottawa 363
Hefei 360
Wilmington 340
Cambridge 334
Seattle 334
Seoul 319
Boardman 248
Princeton 248
Nanjing 235
Izmir 224
Lawrence 218
Lauterbourg 192
Los Angeles 185
Medford 182
Des Moines 175
Tokyo 168
Bern 162
Ho Chi Minh City 149
Lucca 127
Abidjan 119
Dong Ket 118
Grafing 111
Istanbul 103
Dearborn 102
Council Bluffs 93
Buffalo 82
Hanoi 81
Redondo Beach 77
Jüchen 76
Helsinki 74
Pisa 72
Redwood City 71
Rome 69
Nanchang 68
Munich 62
Frankfurt am Main 57
São Paulo 55
Kunming 54
The Dalles 54
London 52
Lagos 51
San Diego 51
Columbus 50
Vienna 50
Lancaster 42
Pontedera 42
Livorno 41
Boulder 40
Hebei 38
Shenyang 38
Bremen 37
Changsha 36
Ogden 36
Orem 36
Pune 36
Tianjin 35
Falls Church 34
Warsaw 34
Brussels 33
Florence 28
Norwalk 28
Dakar 26
Marseille 26
Alessandria 25
Belo Horizonte 25
Guangzhou 24
Jakarta 24
Rio de Janeiro 24
Auburn Hills 23
Chicago 23
Turku 22
Washington 21
Chennai 20
Haiphong 19
Hangzhou 18
Phoenix 18
Amsterdam 17
Fuzhou 17
Mumbai 17
Atlanta 16
Jiaxing 16
Orange 16
Totale 23.041
Nome #
Development and validation of high-performance liquid chromatography method to quantify tavaborole during in vitro transungual permeation studies 275
A water-soluble, mucoadhesive quaternary ammonium chitosan-methyl-β-cyclodextrin conjugate forming inclusion complexes with dexamethasone 269
Liposomes as a potential ocular delivery system of distamycin A 240
Hydrogels for ocular delivery of pilocarpine: Preliminary evaluation in rabbits of the influence of viscosity and of drug solubility 227
POLYMERIC OPHTHALMIC DRUG DELIVERY SYSTEMS: PREPARATION AND EVALUATION OF PILOCARPINE-CONTAINING INSERTS 223
Ionic liquids as potential enhancers for transdermal drug delivery 223
Ciclopirox Hydroxypropyl Chitosan (CPX‐HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application 218
Controlled release of timolol maleate from coated ophthalmic mini-tablets prepared by compression 215
Arabinogalactan as active compound in the management of corneal wounds: In vitro toxicity and in vivo investigations on rabbits 212
Tyrosol-enriched tomatoes by diffusion across the fruit peel from a chitosan coating: a proposal of functional food 212
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits 206
PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies 204
Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization 203
Application of the compression technique to the manifacture of pilocarpina ophthalmic inserts 198
4-Methylbenzylidene camphor microspheres: Reconstituted epidermis (Skinethic®) permeation and distribution 198
In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer 197
Aloe vera as ophthalmic drug delivery: preliminary evaluation 196
Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers 194
Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair 193
Hot-melt extrusion technique (HME) to develop intravitreal inserts 193
Albuterol prodrugs for ocular administration: Synthesis and evaluation of the physico-chemical and IOP-depressant properties of three albuterol triesters 190
pH-responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy 189
Preparation and evaluation in vitro of solutions and o/w microemulsions containing levobunolol as ion-pair 188
Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation 188
Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits 186
Skin permeation and distribution of two sunscreens: a comparison between reconstituted human skin and hairless rat skin 185
Gel-forming erodible inserts for ocular controlled delivery of ofloxacin 184
Nanostructured Drug Delivery Systems for Targeting 5-alpha-Reductase Inhibitors to the Hair Follicle 180
Arabinogalactan: a new ophthalmic vehicle for dry eye protection and treatment of corneal lesions 180
Topical Formulations Containing Finasteride. Part II: Determination of Finasteride Penetration into Hair Follicles using the Differential Stripping Technique 180
Arabinogalattano per uso oculare: caratterizzazione ed efficacia nel processo di riepitelizzazione corneale. 179
Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives 179
Ophthalmic composition containing mucoadhesive polysaccharides able to promote corneal re-epithelization 179
Effect of 5-oxo-2-pyrrolidinecarboxylic acid (PCA) as a new topically applied agent for dry eye syndrome treatment 179
Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits 177
Evaluation of high- and low-molecular weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine 177
Permeation and distribution of ferulic acid and its a-cyclodextrin complex from different formulations in hairless rat skin 176
Healing of rabbits' cornea following laser welding: effect of solid and semisolid formulations containing indocyanine green 176
Inserts for sustained ocular delivery of pilocarpine: evaluation of a series of partial esters of (maleic acid-alkyl vinyl ether) alternating copolymers 175
Rufloxacin eyedrops: effect of different formulations on ocular pharmacokinetics in rabbits 175
Nanostructured Strategies for Melanoma Treatment—Part I: Design and Optimization of Curcumin-Loaded Micelles for Enhanced Anticancer Activity 173
Aqueous ophthalmic formulations containing formocortal solubilised by surfactants or complexing agents 173
A collaborative evaluation of the cytotoxicity of two surfactants by using the human corneal epithelial cell line and the WST-1 test 173
Niaouli oils from different sources: analysis and influence on cutaneous permeation of estradiol in vitro 173
Poloxamer 407 microspheres for orotransmucosal drug delivery. Part II: In vitro/in vivo evaluation 172
Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers 172
Ocular mini-tablets for controlled release of timolol. Evaluation in rabbits 171
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 171
Cytotoxicity on rabbit corneal epithelial cell cultures of some polymers used as ophthalmic adjuvants 169
Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas 168
Development of a Simple Dry Eye Model in the Albino Rabbit and Evaluation of Some Tear Substitutes 167
Nanostructured Strategies for Melanoma Treatment—Part II: Targeted Topical Delivery of Curcumin via Poloxamer-Based Thermosensitive Hydrogels 166
Arabinogalactan in the Re-Epithelization and Glycocalyx Restoration Process of Rabbit Damaged Corneas 166
Evaluation of ocular permeation enhancers: In vitro effects on corneal transport of four ß-blockers, and in vitro/in vivo toxic activity 166
Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system (Odds) for cyclosporine-a 166
Nonpolymeric nanoassemblies for ocular administration of acyclovir: Pharmacokinetic evaluation in rabbits 166
Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid 165
Formulations based on natural ingredients for treatment of nail diseases 165
Liposome-encapsulated mitomycin-C for reduction of corneal healing rate and ocular toxicity. 164
In vitro cutaneous permeation and distrubution of Uvinul MC80 in cosmetic formulations through hairless rat and reconstituted human skin 160
Mucoadhesive liquid ophthalmic vehicles - Evaluation of macromolecular ionic complexes of pilocarpine 160
null 160
Characterization and in vitro evaluation of an (ipn)-hydrogel for transdermal delivery of diltiazem. 159
In vitro evaluation of some parameters involved in mucoadhesion of aqueous polymeric dispersions 159
Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide) 158
Arabinogalactan (AG) in dry eye age-related: a new mucoadhesive and no-viscous ophthalmic vehicle with protective effect on corneal epithelium. Experimental studies. 158
Silicone rubber/hydrogel composite ophthalmic inserts: Preparation and preliminary in vitro/in vivo evaluation 158
Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations 158
Liposomes for ocular delivery of vancomicyn: preparation and in vivo evaluation 157
Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome, 157
Polymeric ophthalmic drug delivery systems. Preparation and evaluation of pilocarpine-containing inserts 156
Rilascio contollato della pilocarpina da matrici oftalmiche preparate per compressione 155
HPCH-based nail lacquers: “ex vivo” study on permeation of three antimycotics through bovine hoof membranes 155
Aloe purificata: formulazioni oftalmiche 155
Opthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization 155
Preparati oftalmici a base di polisaccaridi mucoadesivi con capacità riepitelizzante della cornea 154
Vehicle and enhancer effects on transdermal permeation of estradiol from gel formulations: evaluation in vitro 154
Niaouli oil as enhancer for transdermal permeation of estradiol. Evaluation of gel formulations on hairless rats in vivo 154
Freeze-dried matrices for ocular administration of bevacizumab: a comparison between subconjunctival and intravitreal administration in rabbits 154
Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome 153
Comparison of Liposome-Encapsulated Acyclovir with Acyclovir Ointment: ocular pharmacokinetics in rabbits 153
Effect of Nail Lacquer Composition on In Vitro Transungueal Permeation of Ciclopirox 152
Ocular bioadhesive drug delivery systems 152
Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro 152
[Formulations containing complexes of ophthalmic drugs with tannic acid: "in vitro" and "in vivo" evaluation]. FT Formulazioni contenenti complessi di farmaci oftalmici con acido tannico: preparazione e valutazione "in vitro" e "in vivo". 151
Evaluation in rabbits of a liposomal formulation for ocular delivery of acyclovir 151
Pharmacokinetics and pressure lowering effect in rabbits of timolol in a xyloglucan vehicle 149
Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin 149
Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution 148
Terbinafine nail solutions for topical treatment of onychomycosis: Ex vivo study on penetration/retention through and into keratin membranes 148
Preliminary evaluation of a series of amphiphilic timolol prodrugs: possible evidence for transscleral absorption. 148
Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies 147
Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines 146
Determination of topically applied finasteride penetrated into hair follicles by using the differential stripping technique 146
Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits 145
Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-nano) for ocular delivery of cyclosporine-A 144
Albumin microspheres for ocular delivery of piroxicam 143
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity 143
Iontophoresis and Surfactants Combination on in Vitro Transungual Permeation of Nystatin 143
Nanomicellar eye drops: a review of recent advances 142
Totale 17.365
Categoria #
all - tutte 85.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021421 0 0 0 0 0 0 0 0 0 0 95 326
2021/20222.317 54 202 31 138 426 341 51 96 108 42 104 724
2022/20232.914 349 307 182 281 387 452 58 227 519 9 114 29
2023/20242.308 361 338 301 176 364 341 50 45 37 33 48 214
2024/20256.379 67 275 95 346 596 661 422 445 565 855 765 1.287
2025/20266.462 403 953 831 414 674 724 1.083 253 498 553 76 0
Totale 32.612